Profiles

Keywords
Last Name
Institution

Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.

Davis FA, Stefoski D, Rush J. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990 Feb; 27(2):186-92.

View in: PubMed

collapse authors with profiles